Literature DB >> 21799653

Epidemiological and clinical features of hepatitis B virus related liver failure in China.

Chen Liu1, Yu-Ming Wang, Ke Fan.   

Abstract

AIM: To examine the epidemiologic and clinical characteristics of hepatitis B virus (HBV) related liver failure in patients in China.
METHODS: This study was conducted with a retrospective design to examine 1066 patients with HBV-related liver failure in the southwest of China.
RESULTS: There were more male than female patients. Young and middle-aged people comprised most of the patients. Farmers and laborers comprised the largest proportion (63.09%). Han Chinese accounted for 98.12%, while minority ethnic groups only accounted for 0.88% of patients. A total of 43.47% patients had a family history of HBV-related liver failure and 56.66% patients had a history of drinking alcohol. A total of 42.59% patients with HBV-related liver failure had definite causes. With regard to the clinical manifestation of HBV-related liver failure, the symptoms were: hypodynamia, anorexia and abdominal distension. Total bilirubin (TBIL) and alanine aminotransferase (ALT) levels were altered in 46.23% of patients with evident damage of the liver. Univariate logistic regression analysis showed that the patients' prognoses were correlated with ALT, aspartate aminotransferase, albumin, TBIL, prothrombin activity (PTA), and alpha-fetoprotein levels, and drinking alcohol, ascites, hepatorenal syndrome, infection and ≥ 2 complications. Multifactor logistic regression analysis showed that the activity of thrombinogen and the number of complications were related to the prognosis.
CONCLUSION: Alcohol influences the patients' prognosis and condition. PTA and complications are independent factors that can be used for estimating the prognosis of HBV-related liver failure.

Entities:  

Keywords:  Chronic hepatitis B; Epidemiology; Hepatitis B virus related liver failure; Prognosis

Mesh:

Year:  2011        PMID: 21799653      PMCID: PMC3132258          DOI: 10.3748/wjg.v17.i25.3054

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

Review 1.  Epidemiology of hepatitis B in Europe and worldwide.

Authors:  Miriam J Alter
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

Review 2.  Acute liver failure: avoidance of deleterious cofactors and early specific medical therapy for the liver are better than late intensive care for the brain.

Authors:  Jacques Bernuau
Journal:  J Hepatol       Date:  2004-07       Impact factor: 25.083

3.  [New concept in nomenclature, classification and diagnosis of liver failure].

Authors:  Yu-ming Wang
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2010-11

4.  [A single factor analysis of the prognosis of 301 hepatitis failure cases and a study of a scoring system on their prognostic assessment].

Authors:  Ning Lai; Shu-hua Guo; Da-zhi Zhang; Lei Shi; Xiao-ni Zhong; Chun-lan Yuan
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2005-08

Review 5.  Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card.

Authors:  Richard B Freeman
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

6.  Prognostic factors in severe exacerbation of chronic hepatitis B.

Authors:  Man-Fung Yuen; Erwin Sablon; Chee-Kin Hui; Tak-Ming Li; He-Jun Yuan; Danny Ka-Ho Wong; Joke Doutreloigne; Veerle Bogaerts; Benjamin Chun-Yu Wong; Sheung-Tat Fan; Ching-Lung Lai
Journal:  Clin Infect Dis       Date:  2003-04-02       Impact factor: 9.079

7.  Outcome of pregnancy with severe liver disease.

Authors:  P D Tank; Y S Nadanwar; N M Mayadeo
Journal:  Int J Gynaecol Obstet       Date:  2002-01       Impact factor: 3.561

Review 8.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

9.  Intra-abdominal hypertension: incidence and association with organ dysfunction during early septic shock.

Authors:  Tomas Regueira; Alejandro Bruhn; Pablo Hasbun; Marcia Aguirre; Carlos Romero; Osvaldo Llanos; Ricardo Castro; Guillermo Bugedo; Glenn Hernandez
Journal:  J Crit Care       Date:  2008-04-18       Impact factor: 3.425

10.  Hepatitis B virus infection.

Authors:  Yun-Fan Liaw; Chia-Ming Chu
Journal:  Lancet       Date:  2009-02-14       Impact factor: 79.321

View more
  4 in total

1.  Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey.

Authors:  Shaoli You; Yihui Rong; Bing Zhu; Aimin Zhang; Hong Zang; Hongling Liu; Dongze Li; Zhihong Wan; Shaojie Xin
Journal:  Hepatol Int       Date:  2013-02-07       Impact factor: 6.047

2.  Relationship between hepatocellular carcinoma and hepatitis B virus genotype with spontaneous YMDD mutations.

Authors:  Jia-Hong Yang; Hao Zhang; Xue-Bing Chen; Gao Chen; Xiu Wang
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

3.  A population-based study examining hepatitis B virus infection and immunization rates in Northwest China.

Authors:  Zhaohua Ji; Tingcai Wang; Zhongjun Shao; Dahong Huang; Anhui Wang; Zhiwen Guo; Yong Long; Lei Zhang; Haixia Su; Qi Zhang; Yongping Yan; Daiming Fan
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

4.  Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.

Authors:  I-Cheng Lu; Mei-Chu Yen Jean; Chi-Wei Lin; Wei-Hung Chen; Daw-Shyong Perng; Chih-Wen Lin; Hung-Yi Chuang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.